Zanamivir for assay
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 139110-80-8
Synonym(S): Zanamivir, 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid, 4-Guanidino-Neu5Ac2en
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 MG | Y0001702-50-MG | In Stock | ₹ 15,966.88 |
Y0001702 - 50 MG
In Stock
Quantity
1
Base Price: ₹ 15,966.88
GST (18%): ₹ 2,874.038
Total Price: ₹ 18,840.918
grade
pharmaceutical primary standard
API family
zanamivir
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
InChI
1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
InChI key
ARAIBEBZBOPLMB-UFGQHTETSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Selleck Chemical LLC Zanamivir 2mg 139110-80-8 GG167 | -- | ₹ 15,699.60 | ||
Medchemexpress LLC HY-13210 10mg Medchemexpress, Zanamivir CAS:139110-80-8 Purity:>98% | -- | ₹ 8,410.50 | ||
eMolecules Zanamivir | 139110-80-8 | MFCD00866966 | 50mg | -- | ₹ 5,064.99 | ||
Sigma Aldrich Fine Chemicals Biosciences Zanamivir >=98% (HPLC) | 139110-80-8 | MFCD00866966 | 10MG | -- | ₹ 14,391.30 | ||
Sigma Aldrich Fine Chemicals Biosciences Zanamivir for assay European Pharmacopoeia (EP) Reference Standard | 139110-80-8 | MFCD00866966 | | -- | ₹ 24,531.07 | ||
Sigma Aldrich Fine Chemicals Biosciences Zanamivir United States Pharmacopeia (USP) Reference Standard | 139110-80-8 | MFCD00866966 | 200MG | -- | ₹ 64,167.22 | ||
Zanamivir for system suitability | -- | ₹ 20,794.83 | ||
D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy- | -- | ₹ 2,670.00 - ₹ 1,05,999.00 | ||
139110-80-8 | Zanamivir | -- | ₹ 534.00 - ₹ 1,17,124.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Zanamivir for assay EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Zanamivir is an influenza viral neuraminidase inhibitor.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable